Ver­tex, Seat­tle Ge­net­ics, Alpine with­draw from in­vestor con­fer­ence as biotechs brace for coro­n­avirus

In the first glimpse of how the coro­n­avirus’s grow­ing US spread could dis­rupt op­er­a­tions at Amer­i­can biotechs, a pair of ma­jor com­pa­nies with­drew to­day from a large in­vestor con­fer­ence.

Ver­tex Phar­ma­ceu­ti­cals, Seat­tle Ge­net­ics and Alpine Im­mune were each sched­uled to present Tues­day at the Cowen Health­care Con­fer­ence in Boston. All an­nounced on Mon­day, the first day of the con­fer­ence, they were can­cel­ing their ap­pear­ances, cit­ing the grow­ing spread of the virus, of­fi­cial­ly known as SARS-CoV-2.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER